A comprehensive review of heart failure: Unraveling the etiology, decoding pathophysiological mechanisms, navigating diagnostic modalities, exploring pharmacological interventions, advocating lifestyle modifications, and charting the horizon of emerging therapies in the complex landscape of chronic cardiac dysfunction.

Chibuike Oguine, Mololuwa Adebayo, Omotayo S Alabi, Oluwatosin Afolabi, Mutalib O Ozigis, Otite Akpovona, Nandir J Gonji, Raphael T Nwafor, Aderinsola R Olokodana, Grace O Otobo, Emmanuella E Ozigi, Tanitoluwa M Wusu-Ejalonibu, Joan Asekhauno, Ibirongbe Amos, Nkechinyere Dike, Promise Edochie, Samuel O Onyekweli, Nurudeen Bello, Chidera A Okezie-Okoye, Adediwura T Bayo-Shodipo, Erica Pius, Mercy Asekhauno, Richard Ikpegbu, Dorcas A Amapu, Chigozirim M Agu-Ben, Osinachi K Okoye, Border-Ere Fiemotonghan, Dependable C Amaechi, Temitope I Awotoye, Chukwuka Elendu, Chiagozie P Ayabazu, Tochi C Elendu

Journal: Medicine 2024;103(3):e36895

PMID: 38241566

Abstract

Heart failure (HF) poses a significant global health burden, necessitating a profound understanding of its multifaceted dimensions. This comprehensive review aims to unravel the etiology, decode pathophysiological mechanisms, navigate diagnostic modalities, explore pharmacological interventions, advocate lifestyle modifications, and chart the horizon of emerging therapies in the complex landscape of chronic cardiac dysfunction. The exploration of HF begins with an insightful journey into its diverse etiological factors, encompassing genetic predispositions, hypertension, and coronary artery disease. Delving into pathophysiological mechanisms, this review elucidates the intricate processes of cardiac remodeling, neurohormonal activation, and cellular dysfunction that underlie the progression of HF. Diagnostic modalities play a pivotal role in unraveling the mysteries of HF by examining advanced imaging techniques, biomarkers, and comprehensive clinical assessments. The pharmacological interventions section provides an in-depth analysis of traditional medications, such as diuretics and angiotensin-converting enzyme inhibitors, while highlighting the emergence of novel drug classes transforming HF management. Advocating lifestyle modifications emphasizes the crucial role of diet, exercise, smoking cessation, and alcohol moderation in enhancing patient outcomes. Lastly, the review delves into the promising horizon of emerging therapies, offering a glimpse into current research, innovative treatment approaches, and potential breakthroughs. As HF management faces challenges in patient compliance, healthcare access, and education, this comprehensive review aims to equip healthcare professionals and researchers with a holistic understanding of chronic cardiac dysfunction's intricacies. In conclusion, synthesizing key findings emphasizes the need for an integrated and multidimensional approach to effectively address the complex landscape of heart failure.

Copyright © 2024 the Author(s). Published by Wolters Kluwer Health, Inc.

Address: University of California, Santa Cruz, CA.; Igbinedion University, Okada, Nigeria.; Imo State University, Owerri, Nigeria.; Jackson State University, MS.; Chukwuemeka Odumegwu Ojukwu University Teaching Hospital, Awka, Nigeria.; Kharkiv National Medical University, Kharkiv, Ukraine.; Obafemi Awolowo University, Ife, Nigeria.; Babcock University, Ilishan-Remo, Nigeria.; King's College Hospital NHS Foundation Trust, London, England.; Reddington Multispecialist Hospital, Lagos, Nigeria.; University of Ilorin Teaching Hospital, Ilorin, Nigeria.; University of Osun Teaching Hospital, Osogbo, Nigeria.; Ring Road State Hospital, Ibadan, Nigeria.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.